Lv1
50 积分 2024-08-19 加入
Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study
19小时前
已完结
Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study
21小时前
已完结
Evaluation of Renal Toxicity in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate
21小时前
已完结
Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications
1天前
已完结
Medication safety in chronic kidney disease
1天前
已完结
Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
2天前
已完结
Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First‐Time HBV‐Related Decompensated Cirrhosis
2天前
已完结
OA08.01 BMS-986504 in Patients With Homozygous MTAP-Deletion (Del): Clinical Results in Patients With NSCLC Enrolled in CA240-0007
8天前
已关闭
Targeting the Synthetic Lethal Relationship between FOCAD and TUT7 Represents a Potential Therapeutic Opportunity for TUT4/7 Small-Molecule Inhibitors in Cancer
15天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
17天前
已完结
皖公网安备34019202002308
